IGC Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IGC Pharma and other ETFs, options, and stocks.

About IGC

IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. 

CEO
Ram Mukunda
CEORam Mukunda
Employees
67
Employees67
Headquarters
Potomac, Maryland
HeadquartersPotomac, Maryland
Founded
2005
Founded2005
Employees
67
Employees67

IGC Key Statistics

Market cap
23.94M
Market cap23.94M
Price-Earnings ratio
-2.44
Price-Earnings ratio-2.44
Dividend yield
Dividend yield
Average volume
222.87K
Average volume222.87K
High today
$0.3004
High today$0.3004
Low today
$0.2951
Low today$0.2951
Open price
$0.2952
Open price$0.2952
Volume
18.84K
Volume18.84K
52 Week high
$0.633
52 Week high$0.633
52 Week low
$0.2525
52 Week low$0.2525

People also own

Based on the portfolios of people who own IGC. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.